Your browser doesn't support javascript.
loading
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.
Turkova, Anna; Waalewijn, Hylke; Chan, Man K; Bollen, Pauline D J; Bwakura-Dangarembizi, Mutsa F; Kekitiinwa, Adeodata R; Cotton, Mark F; Lugemwa, Abbas; Variava, Ebrahim; Ahimbisibwe, Grace Miriam; Srirompotong, Ussanee; Mumbiro, Vivian; Amuge, Pauline; Zuidewind, Peter; Ali, Shabinah; Kityo, Cissy M; Archary, Moherndran; Ferrand, Rashida A; Violari, Avy; Gibb, Diana M; Burger, David M; Ford, Deborah; Colbers, Angela.
Afiliação
  • Turkova A; Medical Research Council Clinical Trials Unit, University College London, London, UK. Electronic address: a.turkova@ucl.ac.uk.
  • Waalewijn H; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands.
  • Chan MK; Medical Research Council Clinical Trials Unit, University College London, London, UK.
  • Bollen PDJ; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands.
  • Bwakura-Dangarembizi MF; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe.
  • Kekitiinwa AR; Baylor College of Medicine, Kampala, Uganda.
  • Cotton MF; Children's Infectious Diseases Clinical Research Unit, Family Center for Research with Ubuntu, Department of Paediatrics and Child Health, University of Stellenbosch, Cape Town, South Africa.
  • Lugemwa A; Joint Clinical Research Centre, Mbarara, Uganda.
  • Variava E; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Ahimbisibwe GM; Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda.
  • Srirompotong U; Pediatric Department, Khon Kaen Hospital, Khon Kaen, Thailand.
  • Mumbiro V; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe.
  • Amuge P; Baylor College of Medicine, Kampala, Uganda.
  • Zuidewind P; Children's Infectious Diseases Clinical Research Unit, Family Center for Research with Ubuntu, Department of Paediatrics and Child Health, University of Stellenbosch, Cape Town, South Africa.
  • Ali S; Medical Research Council Clinical Trials Unit, University College London, London, UK.
  • Kityo CM; Joint Clinical Research Centre, Kampala, Uganda.
  • Archary M; Department of Paediatrics and Child Health, King Edward VIII Hospital, Enhancing Care Foundation, University of KwaZulu-Natal, Durban, South Africa.
  • Ferrand RA; London School of Hygiene & Tropical Medicine, London, UK.
  • Violari A; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Gibb DM; Medical Research Council Clinical Trials Unit, University College London, London, UK.
  • Burger DM; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands.
  • Ford D; Medical Research Council Clinical Trials Unit, University College London, London, UK.
  • Colbers A; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands.
Lancet HIV ; 9(9): e627-e637, 2022 09.
Article em En | MEDLINE | ID: mdl-35868341

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Infecções por HIV / HIV-1 Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Africa Idioma: En Revista: Lancet HIV Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Infecções por HIV / HIV-1 Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Africa Idioma: En Revista: Lancet HIV Ano de publicação: 2022 Tipo de documento: Article